SEC Investigates Jobs’ Health

The Securities and Exchange Commission is launching an investigation to make sure investors weren't misled by announcements over Steve Jobs's health and decision to take a leave of absence.

When the head of Apple, Steve Jobs, announced that he was simply suffering from a hormone imbalance, not cancer, Apple shares rocketed. Not long after, when he told the world that his condition was more complex than previously thought and that he was taking a leave of absence, shares dropped again.

Now the Securities and Exchange Commission (SEC) is launching an investigation to look into the sequence of events and make sure investors weren’t misled, according to Bloomberg.

It comes in the wake of rumors of lawsuits by investors, although the SEC is at pains to point out that it doesn’t have any evidence of wrongdoing. Bloomberg reported last week that Jobs might need a liver transplant.

During his leave of absence, Jobs will reportedly remain on the board of Disney.